Joel Greenblatt Harmony Biosciences Holdings, Inc. Transaction History
Gotham Asset Management, LLC
- $10.2 Billion
- Q4 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 50,502 shares of HRMY stock, worth $1.49 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,502
Previous 66,722
24.31%
Holding current value
$1.49 Million
Previous $2.67 Million
34.82%
% of portfolio
0.02%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding HRMY
# of Institutions
260Shares Held
46.9MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$195 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$172 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$140 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$67.3 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$46.7 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.75B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...